Lilly(Eli) & Co (LLY)

Precedente Chiudi:

$755.91

Aprire:

$743

Volume 24 ore:

4.50M

Capitalizzazione di mercato:

$698.52B

Reddito:

$35.93B

Utile/perdita netta:

$6.14B

Rapporto P/E:

135.62

EPS:

5.4193

Flusso di cassa netto:

$-3.90B

1 W Prestazione:

+0.20%

1M Prestazione:

-5.29%

6M Prestazione:

+29.44%

1 anno Prestazione:

+70.45%

Intervallo 1D:

$730.34

$745.00

Portata 52W:

$419.80

$800.78

Lilly(Eli) & Co Stock (LLY) Company Profile

Nome

Lilly(Eli) & Co

Settore

Healthcare (1213)

Industria

Drug Manufacturers - General (18)

Telefono

317-276-2000

Indirizzo

Lilly Corporate Center, Indianapolis, IN

Dipendente

38,585

Cinguettio

@LillyPad

Prossima data di guadagno

2024-05-06

Ultimi documenti SEC

LLY's Discussions on Twitter

Lilly(Eli) & Co Stock (LLY) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-02-21	Downgrade	DZ Bank	Buy → Hold
2024-02-16	Reiterato	Morgan Stanley	Overweight
2023-12-21	Downgrade	Daiwa Securities	Buy → Outperform
2023-11-09	Iniziato	Deutsche Bank	Hold
2023-10-20	Ripresa	UBS	Buy
2023-08-09	Aggiornamento	Jefferies	Hold → Buy
2023-07-26	Reiterato	Citigroup	Buy
2023-07-14	Iniziato	HSBC Securities	Buy
2023-05-24	Reiterato	BofA Securities	Buy
2023-05-24	Reiterato	UBS	Buy
2023-03-13	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2023-03-06	Iniziato	Jefferies	Hold
2023-02-15	Downgrade	Societe Generale	Hold → Sell
2022-11-18	Iniziato	Credit Suisse	Outperform
2022-09-22	Aggiornamento	UBS	Neutral → Buy
2022-05-23	Iniziato	SVB Leerink	Outperform
2022-04-06	Ripresa	Morgan Stanley	Overweight
2022-03-10	Iniziato	Daiwa Securities	Outperform
2022-01-21	Aggiornamento	DZ Bank	Hold → Buy
2022-01-03	Reiterato	Bernstein	Mkt Perform
2021-12-17	Iniziato	Goldman	Neutral
2021-12-16	Reiterato	BMO Capital Markets	Outperform
2021-12-16	Reiterato	BofA Securities	Buy
2021-12-09	Ripresa	Wells Fargo	Equal Weight
2021-11-19	Iniziato	BMO Capital Markets	Outperform
2021-10-11	Aggiornamento	Berenberg	Hold → Buy
2021-09-29	Aggiornamento	Citigroup	Neutral → Buy
2021-08-05	Aggiornamento	DZ Bank	Hold → Buy
2021-07-27	Ripresa	Truist	Buy
2021-06-24	Reiterato	Cantor Fitzgerald	Overweight
2021-01-19	Aggiornamento	Mizuho	Neutral → Buy
2020-12-10	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2020-11-10	Ripresa	Bernstein	Mkt Perform
2020-09-29	Iniziato	Berenberg	Hold
2020-09-03	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-06-16	Aggiornamento	Guggenheim	Neutral → Buy
2020-04-21	Downgrade	UBS	Buy → Neutral
2020-04-09	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-02-06	Iniziato	Mizuho	Neutral
2019-12-18	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2019-10-17	Ripresa	BofA/Merrill	Buy
2019-05-28	Iniziato	Goldman	Buy
2019-04-24	Aggiornamento	Edward Jones	Hold → Buy
2019-04-11	Downgrade	Guggenheim	Buy → Neutral
2019-03-12	Iniziato	JP Morgan	Overweight
2019-01-23	Iniziato	UBS	Buy
2018-11-26	Downgrade	Citigroup	Buy → Neutral
2018-10-31	Aggiornamento	Credit Suisse	Underperform → Neutral
2018-10-09	Iniziato	Guggenheim	Buy
2018-10-01	Reiterato	SunTrust	Buy
2018-09-26	Ripresa	JP Morgan	Overweight

Mostra tutto

Lilly(Eli) & Co Borsa (LLY) Ultime notizie

Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making

The Motley Fool

Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?

The Motley Fool

Why Amgen Stock Zoomed Nearly 12% Higher Today

The Motley Fool

Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update

Zacks Investment Research

Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims

Zacks Investment Research

Wage Growth Slows – Stock Market Celebrates, Five Real Reasons Apple Is Running Up

Benzinga

Lilly(Eli) & Co Azioni (LLY) Dati Finanziari

Lilly(Eli) & Co (LLY) Reddito 2024

Lilly(Eli) & Co (LLY) Reddito netto 2024

Lilly(Eli) & Co (LLY) Flusso di cassa 2024

Lilly(Eli) & Co (LLY) Utile per azione 2024

Lilly(Eli) & Co Azioni (LLY) insider trading